289 related articles for article (PubMed ID: 26315722)
1. CHO expressed recombinant human lactoferrin as an adjuvant for BCG.
Hwang SA; Kruzel ML; Actor JK
Int J Immunopathol Pharmacol; 2015 Dec; 28(4):452-68. PubMed ID: 26315722
[TBL] [Abstract][Full Text] [Related]
2. Immune Activity of BCG Infected Mouse Macrophages Treated with a Novel Recombinant Mouse Lactoferrin.
O'Shea KM; Hwang SA; Actor JK
Ann Clin Lab Sci; 2015; 45(5):487-94. PubMed ID: 26586698
[TBL] [Abstract][Full Text] [Related]
3. Lactoferrin enhances efficacy of the BCG vaccine: comparison between two inbred mice strains (C57BL/6 and BALB/c).
Hwang SA; Arora R; Kruzel ML; Actor JK
Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S49-54. PubMed ID: 20006305
[TBL] [Abstract][Full Text] [Related]
4. Effects of CHO-expressed recombinant lactoferrins on mouse dendritic cell presentation and function.
Hwang SA; Kruzel ML; Actor JK
Innate Immun; 2015 Jul; 21(5):553-61. PubMed ID: 25537452
[TBL] [Abstract][Full Text] [Related]
5. Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis.
Hwang SA; Wilk KM; Budnicka M; Olsen M; Bangale YA; Hunter RL; Kruzel ML; Actor JK
Vaccine; 2007 Sep; 25(37-38):6730-43. PubMed ID: 17698261
[TBL] [Abstract][Full Text] [Related]
6. Comparing efficacy of BCG/lactoferrin primary vaccination versus booster regimen.
Hwang SA; Welsh KJ; Boyd S; Kruzel ML; Actor JK
Tuberculosis (Edinb); 2011 Dec; 91 Suppl 1():S90-5. PubMed ID: 22088320
[TBL] [Abstract][Full Text] [Related]
7. Lactoferrin augments BCG vaccine efficacy to generate T helper response and subsequent protection against challenge with virulent Mycobacterium tuberculosis.
Hwang SA; Kruzel ML; Actor JK
Int Immunopharmacol; 2005 Mar; 5(3):591-9. PubMed ID: 15683854
[TBL] [Abstract][Full Text] [Related]
8. A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice.
Hwang SA; Wilk K; Kruzel ML; Actor JK
Vaccine; 2009 May; 27(23):3026-34. PubMed ID: 19428915
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin modulation of BCG-infected dendritic cell functions.
Hwang SA; Actor JK
Int Immunol; 2009 Oct; 21(10):1185-97. PubMed ID: 19692539
[TBL] [Abstract][Full Text] [Related]
10. Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression.
Kruzel ML; Actor JK; Zimecki M; Wise J; Płoszaj P; Mirza S; Kruzel M; Hwang SA; Ba X; Boldogh I
J Biotechnol; 2013 Dec; 168(4):666-75. PubMed ID: 24070904
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Tat protein vaccination in mice infected with Mycobacterium tuberculosis is safe, immunogenic and reduces bacterial lung pathology.
Cafaro A; Piccaro G; Altavilla G; Gigantino V; Matarese G; Olivieri E; Ferrantelli F; Ensoli B; Palma C
BMC Infect Dis; 2016 Aug; 16(1):442. PubMed ID: 27549342
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis proteins involved in cell wall lipid biosynthesis improve BCG vaccine efficacy in a murine TB model.
Rao M; Cadieux N; Fitzpatrick M; Reed S; Arsenian S; Valentini D; Parida S; Dodoo E; Zumla A; Maeurer M
Int J Infect Dis; 2017 Mar; 56():274-282. PubMed ID: 28161464
[TBL] [Abstract][Full Text] [Related]
13. CpG oligodeoxynucleotides and interleukin-12 improve the efficacy of Mycobacterium bovis BCG vaccination in mice challenged with M. tuberculosis.
Freidag BL; Melton GB; Collins F; Klinman DM; Cheever A; Stobie L; Suen W; Seder RA
Infect Immun; 2000 May; 68(5):2948-53. PubMed ID: 10768993
[TBL] [Abstract][Full Text] [Related]
14. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
15. Recombinant BCG With Bacterial Signaling Molecule Cyclic di-AMP as Endogenous Adjuvant Induces Elevated Immune Responses After
Ning H; Wang L; Zhou J; Lu Y; Kang J; Ding T; Shen L; Xu Z; Bai Y
Front Immunol; 2019; 10():1519. PubMed ID: 31333655
[TBL] [Abstract][Full Text] [Related]
16. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
17. Enhanced effect of BCG vaccine against pulmonary Mycobacterium tuberculosis infection in mice with lung Th17 response to mycobacterial heparin-binding hemagglutinin adhesin antigen.
Fukui M; Shinjo K; Umemura M; Shigeno S; Harakuni T; Arakawa T; Matsuzaki G
Microbiol Immunol; 2015 Dec; 59(12):735-43. PubMed ID: 26577130
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Immunogenicity and Protective Efficacy Elicited by Mycobacterium bovis BCG Overexpressing Ag85A Protein against Mycobacterium tuberculosis Aerosol Infection.
Xu ZZ; Chen X; Hu T; Meng C; Wang XB; Rao Y; Zhang XM; Yin YL; Pan ZM; Jiao XA
Front Cell Infect Microbiol; 2016; 6():3. PubMed ID: 26858942
[TBL] [Abstract][Full Text] [Related]
19. Repeated Aerosolized-Boosting with Gamma-Irradiated Mycobacterium bovis BCG Confers Improved Pulmonary Protection against the Hypervirulent Mycobacterium tuberculosis Strain HN878 in Mice.
Cha SB; Kim WS; Kim JS; Kim H; Kwon KW; Han SJ; Eum SY; Cho SN; Shin SJ
PLoS One; 2015; 10(10):e0141577. PubMed ID: 26509812
[TBL] [Abstract][Full Text] [Related]
20. The influence of interferon-β supplemented human dendritic cells on BCG immunogenicity.
El-Sahrigy SAF; Rahman AMOA; Samaha DY; Mohamed NA; Saber SM; Talkhan HA; Ismail GA; Ibraheem EM; Riad EM
J Immunol Methods; 2018 Jun; 457():15-21. PubMed ID: 29522775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
